Exogenous tyrosol inhibits planktonic cells and biofilms of Candida species and enhances their susceptibility to antifungals

FEMS Yeast Research

Volumn 15, Issue 4, 2015, Pages

  Cordeiro, Rossana de A ^a   Teixeira, Carlos E C ^a   Brilhante, Raimunda S N ^a   Castelo Branco, Débora S C M ^a   Alencar, Lucas P ^a,b   de Oliveira, Jonathas S ^a   Monteiro, Andŕe J ^a   Bandeira, Tereza J P G ^a   Sidrim, Jośe J C ^a   Moreira, Jośe Luciano Bezerra ^a   Rocha, Marcos F G ^a,b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Biofilms; Candida; Susceptibility; Synergism; Tyrosol

Indexed keywords

AMPHOTERICIN B; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE; TYROSOL; 4-HYDROXYPHENYLETHANOL; ANTIFUNGAL AGENT; PHENETHYL ALCOHOL;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; ANALOGS AND DERIVATIVES; CANDIDA; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; DRUG SYNERGISM; FLUCONAZOLE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; PHENYLETHYL ALCOHOL;

EID: 84949222484     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1093/femsyr/fov012     Document Type: Article

References (50)

1. Ahmad S, Khan Z, Asadzadeh M, et al. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infect Dis 2012;12:230.
2. Albuquerque P, Casadevall A. Quorum sensing in fungi: a review. Med Mycol 2012;50:337-45.
3. Alem MAS, Oteef MDY, Flowers TH, et al. Production of tyrosol by Candida albicans biofilms and its role in Quorum Sensing and biofilm development. Eukaryot Cell 2006;5:1770-9.
4. Bink A, Kuchaŕiková S, Neirinck B, et al. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. J Infect Dis 2012;1:1790-7.
5. Brilhante RSN, Paiva MAN, Sampaio CMS, et al. Yeasts from Macrobrachium amazonicum: a focus on antifungal susceptibility and virulence factors of Candida spp. FEMS Microbiol Ecol 2011;76:268-77.
6. Brilhante RSN, Valente LGA, Rocha MFG, et al. Sesquiterpene farnesol contributes to increased susceptibility to ß-lactams in strains of Burkholderia pseudomallei. Antimicrob Agents Chemother 2012;56:2198-200.
7. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis: systematic review. J Infect 2007;54:521-9.
8. Brito EHS, Fontenelle ROS, Brilhante RSN, et al. The anatomical distribution and antimicrobial susceptibility of yeast species isolated from healthy dogs. Vet J 2009;182:320-6.
9. Cabanẽs FJ. Yeast pathogens of domestic animals. In: Ashbee R, Bignell EM (eds). Pathogenic Yeasts, the Yeast Handbook, 2nd edn. Berlin: Springer, 2010, 253-79.
10. Cao YY, Cao YB, Xu Z, et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 2005;49:584-9.
11. Castelo-Branco DS, Brilhante RS, Paiva MA, et al. Azole-resistant Candida albicans from a wild Brazilian porcupine (Coendou prehensilis): a sign of an environmental imbalance? Med Mycol 2013;51:555-60.
12. Chaturvedi V, Ramani R, Andes D, et al. Multilaboratory testing of two drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother 2011;55:1543-8.
13. Chatzimoschou A, Katragkou S, Simitsopoulou M, et al. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrob Agents Chemother 2011;55:1968-74.
14. Chen H, Fink GR. Feedback control ofmorphogenesis in fungi by aromatic alcohols. Gene Dev 2006;20:1150-61.
15. Chen H, Fujita M, Feng Q, et al. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA 2004;101:5048-52.
16. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts;Aproved Standart, Document M27-A3. Clinical Laboratory Standards Institute (CLSI), Wayne, PA, USA, 2008.
17. Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816-23.
18. Cordeiro RA, Teixeira CEC, Brilhante RSN, et al. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. Med Mycol 2013;51:53-9.
19. Crawshaw WM, MacDonald NR, Duncan G. Outbreak of Candida rugosa mastitis in a dairy herd after intramammary antibiotic treatment. Vet Rec 2005;156:812-3.
20. Cúellar-Cruz M, Vega-Gonźalez A, Mendoza-Novelo B, et al. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Eur J Clin Microbiol Infect Dis 2012;31:2513-27.
21. Davis-Hanna A, Piispanen AE, Stateva LI, et al. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 2008;67:47-62.
22. De Hoog GS, Guarro J, Gene J, et al. Atlas of Clinical Fungi, 2nd edn. Utrecht/Reus: Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000.
23. Derengowski LS, De-Souza-Silva C, Braz SV, et al. Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob 2009;29:8-13.
24. Dinamarco TM, Goldman MHS, Goldman GH. Farnesol-induced cell death in the filamentous fungus Aspergillus nidulans. Biochem Soc Trans 2011;39:1544-8.
25. Garnacho-Montero J, Díaz-Martín A, Garćia-Cabrera E, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother 2010;54:3149-54.
26. Gaudie CM, Wragg PN, Barber AM. Outbreak of disease due to Candida krusei in a small dairy herd in the UK. Vet Rec 2009;165:535-7.
27. Lamm CG, Grune SC, Estrada MM, et al. Granulomatous rhinitis due to Candida parapsilosis in a cat. J Vet Diagn Invest 2013;25:596-8.
28. Li Y, Ma Y, Zhang L, et al. In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D. PLoS One 2012;7:e35543.
29. Lindsay AK, Deveau A, Piispanen AE, et al. Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans. Eukaryot Cell 2012;11:1219-25.
30. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011;11:142-51.
31. Negri M, Silva S, Henriques M, et al. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 2012;31:1399-412.
32. Neppelenbroek KH, Séo RS, Urban VM, et al. Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Dis 2014;20:329-44.
33. Nucci M, Queiroz-Telles F, Tobón AM, et al. Epidemiology of opportunistic fungal infections in Latin America. Clin Infec Dis 2010;51:561-70.
34. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. Antimicrob Chemother 2003;52:1. Osorio C, Fletcher O, Dykstra MJ, et al. Comb candidiasis affecting roosters in a broiler breeder flock. Avian Dis 2007;51: 618-22.
35. Osorio C, Fletcher O, Dykstra MJ, et al. Comb candidiasis affecting roosters in a broiler breeder flock. Avian Dis 2007;51: 618-22
36. Pfaller MA, Andes D, Diekema DJ, et al. Wild-type MIC distributions, epidemiological cutoffvalues and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Update 2010;13:180-95.
37. Ramage G, Rajendran R, Sherry L, et al. Fungal biofilm resistance. Int J Microbiol 2012;2012:1-12.
38. Ramage G, Robertson SN, Williams C. Strength in numbers: antifungal strategies against fungal biofilms. Int J Antimicrob Agents 2014;43:114-20.
39. Ramage G, Saville SP, Wickes BL, et al. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microb 2002;68:5459-63.
40. Rogers CL, Gibson C, Mitchell SL, et al. Disseminated candidiasis secondary to fungal and bacterial peritonitis in a young dog. J Vet Emerg Crit Care 2009;19:193-8.
41. Sidrim JJC, Castelo-Branco DSCM, Brilhante RSN, et al. Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity. Vet Microbiol 2010;145: 324-8.
42. Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012;36:288-305.
43. Skoric M, Fictum P, Slana I, et al. A case of systemic mycosis in a Hovawart dog to Candida albicans. Vet Med 2011;56:260-4.
44. TaffHT, Mitchell KF, Edward JA, et al. Mechanisms of Candida biofilm drug resistance. Future Microbiol 2013;8:1325-37.
45. Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007;45:1843-50.
46. Uppuluri P, Nett J, Heitman J, et al. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 2008;52:1127-32.
47. Visioli F, Galli C, Bornet F, et al. Olive oil phenolics are dosedependently absorbed in humans. FEBS Lett 2000;468:159-60.
48. Weber K, Sohr R, Schulz B, et al. Secretion of E, E-farnesol and biofilm formation in eight different Candida species. Antimicrob Agents Chemother 2008;52:1859-61.
49. Yu LH, Wei X, Ma M, et al. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. Antimicrob Agents Chemother 2012;56:770-5.
50. Zlotowski P, Rozza DB, Pescador CA, et al. Muco-cutaneous candidiasis in two pigs with post weaning multisystemic wasting syndrome. Vet J 2006;3:566-9.